SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-001194
Filing Date
2019-01-25
Accepted
2019-01-24 21:59:13
Documents
3
Period of Report
2018-01-21
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k012118_adialpharma.htm 8-K 21035
2 PRESS RELEASE OF ADIAL PHARMACEUTICALS, INC. DATED JANUARY 24, 2019 f8k012118ex99-1_adial.htm EX-99.1 8744
3 GRAPHIC ex99-1_001.jpg GRAPHIC 3967
  Complete submission text file 0001213900-19-001194.txt   36775
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38323 | Film No.: 19541117
SIC: 2834 Pharmaceutical Preparations